发明名称 |
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors |
摘要 |
The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer. |
申请公布号 |
US9580419(B2) |
申请公布日期 |
2017.02.28 |
申请号 |
US201514799777 |
申请日期 |
2015.07.15 |
申请人 |
Incyte Corporation;Incyte Holdings Corporation |
发明人 |
Rodgers James D.;Wang Haisheng;Combs Andrew P.;Sparks Richard B. |
分类号 |
C07D401/02;C07D401/10;A61K31/437;C07D471/04;C07D487/04 |
主分类号 |
C07D401/02 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A method of treating dermatitis in a patient, comprising topically administering to said patient a therapeutically effective amount of a compound which is 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-piperidin-1-yl}-3-oxo-propionitrile, or a pharmaceutically acceptable salt thereof. |
地址 |
Wilmington DE US |